TECX — Tectonic Therapeutic Balance Sheet
0.000.00%
- $369.83m
- $101.91m
Annual balance sheet for Tectonic Therapeutic, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 28.1 | 36 | 28.8 | 141 |
| Prepaid Expenses | ||||
| Total Current Assets | 28.6 | 37 | 30.9 | 147 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 3.66 | 9.55 | 7.23 | 5.3 |
| Other Long Term Assets | ||||
| Total Assets | 32.9 | 47.2 | 39.4 | 153 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 4.12 | 7.84 | 40.9 | 11.6 |
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 5.23 | 12.2 | 43.4 | 12.1 |
| Redeemable Preferred Stock | ||||
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 27.6 | 35 | -4.01 | 141 |
| Total Liabilities & Shareholders' Equity | 32.9 | 47.2 | 39.4 | 153 |
| Total Common Shares Outstanding |